|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.24 USD | +5.76% |
|
+10.23% | +22.67% |
| May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
| May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
Wave Life Sciences Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 12.93 million compared to USD 1.75 million a year ago. Net loss was USD 27.41 million compared to USD 37.81 million a year ago.
Basic loss per share from continuing operations was USD 0.27 compared to USD 0.62 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +22.67% | 723M | |
| +8.87% | 114B | |
| +11.47% | 104B | |
| -12.65% | 22.41B | |
| -1.05% | 22.28B | |
| -5.29% | 19.07B | |
| -38.29% | 18B | |
| -3.12% | 17.89B | |
| +8.33% | 14.28B | |
| +34.99% | 12.55B |
WAVE LIFE SCIENCES LTD. 
